Investigating Breast Cancer artwork

Investigating Breast Cancer

78 episodes - English - Latest episode: 27 days ago - ★★★★★ - 93 ratings

Official podcast of the Breast Cancer Research Foundation

Life Sciences Science Health & Fitness Medicine
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

Improving Treatments for Invasive Lobular Carcinoma with Dr. Adrian Lee

March 28, 2024 17:20 - 20 minutes - 18.4 MB

In the latest episode of Investigating Breast Cancer, Dr. Adrian Lee discusses collaboration, strategies to improve treatment for ILC, and more. A BCRF investigator since 2013, he is the Pittsburgh Foundation chair and director of the Institute for Precision Medicine at the University of Pittsburgh and UPMC

Improving Breast Cancer Radiation Treatments with Dr. Rachel Jimenez

February 28, 2024 20:30 - 24 minutes - 22.3 MB

In the latest episode, Dr. Rachel Jimenez discusses a new strategy of delivering radiation called proton beam radiation that could reduce treatment time and minimize its damaging effects on the heart. Unlike traditional radiation, proton therapy radiation can target cancer cells specifically, sparing other healthy tissues from potential damage. Dr. Jimenez is an assistant professor of radiation oncology at Harvard Medical School and the chair for quality and safety in the department of radi...

The Effects of a High-Fiber Diet in Early-Stage Breast Cancer with Dr. Laura Esserman

January 17, 2024 20:45 - 28 minutes - 25.9 MB

Dr. Laura Esserman talks about her current research that examines how fiber shapes the gut microbiome, potentially improving the response to immune agents in women newly diagnosed with breast cancer. Her prior research looked at how immune cells in tumors influence tumor response to immune drugs, and she believes the gut microbiome plays a key role in this complex system. A BCRF investigator since 1998, Dr. Esserman is an internationally recognized breast surgeon, breast oncology special...

BCRF 2023 New York City Symposium

December 13, 2023 20:48 - 1 hour - 64.4 MB

In October, BCRF holds its annual New York Symposium and Awards Luncheon. The event recognizes BCRF-supported investigators for their devotion to ending breast cancer and announces the Foundation’s research investment for the coming year. In this special episode of Investigating Breast Cancer, you’ll hear this year’s  extraordinary symposium, co-moderated by BCRF Founding Scientific Director Dr. Larry Norton and BCRF Scientific Director Dr. Judy Garber, that included Drs. Seema Khan, Consta...

Investigating Novel Biomarkers for Personalized Treatments with Dr. Roisin Connolly

November 15, 2023 22:30 - 31 minutes - 29 MB

Breast cancer is a profoundly personal disease, and blanket approaches may not work for all patients. In fact, some can avoid particular therapies or treatments altogether. BCRF investigators have played a significant role in developing precision medicine and individualized therapies, improving treatment efficacy and limiting side effects. This is the area where Dr. Roisin Connolly’s work is centered. In this latest episode Dr. Connolly discusses her work to uncover more personalized treatm...

Reflecting on Thirty Years of Progress with Dr. Larry Norton

September 26, 2023 06:00 - 37 minutes - 34.8 MB

Since Evelyn H. Lauder and Dr. Larry Norton launched BCRF in 1993 remarkable advances in breast cancer prevention, diagnosis, treatment, survivorship, and metastasis have been made. But there is still critical work to be done. The Foundation is moving faster and closer than ever to achieving its mission to prevent and cure breast cancer by advancing the world’s most promising research.  We spoke with BCRF co-founder and Founding Scientific Director, Dr. Larry Norton to discuss the progress ...

The Progress and Future of Breast Cancer Vaccines with Dr. Nora Disis

September 05, 2023 06:00 - 28 minutes - 25.8 MB

In this latest episode of Investigating Breast Cancer, Dr. Nora Disis talks about prevention, treatment, breast cancer vaccine research, and more. Her research focuses on identifying ways to boost the immune response in breast cancer patients to improve chemotherapy outcomes. She is working on discovering new molecular immunologic targets in solid tumors to develop vaccines and cellular therapy for treating and preventing breast cancer. Dr. Disis, a BCRF investigator since 2016, is the Ath...

The Future of Breast Cancer Risk Prediction with Dr. Regina Barzilay

August 13, 2023 16:18 - 24 minutes - 22.9 MB

There are some technologies that enhance human efforts and abilities and other technologies that make such a drastic impact–– they revolutionize protocol and entire ways of thinking. AI in the healthcare field is one such technology. Scientists like BCRF Investigator, Dr. Regina Barzilay, are working on ways to harness AI to improve how medical professionals interpret mammograms, and finesse and better personalize existing risk prediction models, and tackle disparities in screening and risk ...

Lowering Barriers to Breast Cancer Genetic Testing with Dr. Susan Domchek

June 23, 2023 18:07 - 24 minutes - 22.4 MB

Why have so many individuals who carry BRCA mutations not undergone genetic testing and counseling? How do we eliminate barriers to this lifesaving care? Dr. Susan Domchek talks about her work to tackle these issues and more in the latest episode of BCRF's official podcast, Investigating Breast Cancer.

Studying Breast Cancer Risk in Asian American Communities with Dr. Scarlett Gomez

May 23, 2023 17:59 - 23 minutes - 21.7 MB

What elements of our environment are carcinogenic? What role do factors like age, diet, and genetics play? And because cancer is biological in nature, many of us tend to think about the individual and their body as an obvious point of focus. What about, though, the larger, societal picture? That’s what Dr. Scarlett Gomez and the field of social epidemiology are working to uncover and what you’ll hear about in this latest episode.

Bridging the Gap Between the Lab and Patient Care with Dr. Ian Krop

April 20, 2023 16:10 - 28 minutes - 26.4 MB

In the latest episode of Investigating Breast Cancer, Dr. Ian Krop discusses his team’s work to advance clinical trials through—including one to test immunotherapy in HER2-positive breast cancer. A BCRF investigator since 2017, Dr. Krop is the chief clinical research officer and associate cancer center director for clinical research at the Yale Cancer Center. Dr. Krop also currently serves as chief scientific officer for the BCRF-supported Translational Breast Cancer Research Consortium.

Understanding and Targeting Triple-Negative Breast Cancer with Dr. Jill Bargonetti

March 03, 2023 14:44 - 29 minutes - 27 MB

The complexities of triple-negative breast cancer (TNBC) can sometimes make it hard to understand. It’s an aggressive form of breast cancer that is more likely to spread to other tissues––a process called metastasis. BCRF Investigator since 2005, Dr. Jill Bargonetti’s research works to break down some of the complexities of TNBC. Her research has put her at the forefront of how we might develop novel strategies to accurately identify and kill these cells. In this latest episode of Investig...

Exploring Social Determinants of Health in Breast Cancer Care with Dr. Sonya Reid

March 02, 2023 03:13 - 24 minutes - 22.7 MB

Why are Black women 40 percent more likely to die from breast cancer than white women? And why is it such a challenge to make clinical trials reflect everyone who faces breast cancer? That’s what Dr. Sonya Reid and her team are working to uncover by addressing disparities in breast cancer diagnosis and treatment through research. Dr. Reid is an assistant professor of hematology/oncology at Vanderbilt University Medical Center. Her three-year Conquer Cancer–BCRF grant was made possible by T...

BCRF Investigators Discuss the Latest in Breast Cancer Research at 2022 Symposium

December 19, 2022 16:39 - 59 minutes - 54.2 MB

Each October, BCRF holds its annual New York Symposium and Awards Luncheon. The event recognizes BCRF-supported investigators for their devotion to ending breast cancer and announces the Foundation’s research investment for the coming year. This year’s program included an extraordinary symposium, co-moderated by BCRF Founding Scientific Director Dr. Larry Norton and BCRF Scientific Director Dr. Judy Garber, that included Drs. Lisa Newman, Andrew Tutt, and Maria Jasin, who discussed novel br...

Finding and Targeting “Sleeping” Cancer Cells with Dr. Angela DeMichele

November 22, 2022 15:47 - 28 minutes - 25.9 MB

What are dormant cancer cells and how they lead to a clearer understanding of the cancer in remission? Why do particular cancerous cells behave differently than others? BCRF Investigator since 2017, Dr. Angela DeMichele, discusses her work to uncover the answer to these questions and more.

Investigating What Drives Recurrence and Metastasis with Dr. Christina Curtis

October 17, 2022 18:41 - 28 minutes - 9.85 MB

About 30 percent of people diagnosed with early-stage breast cancer will experience a recurrence and develop metastatic disease. Dr. Christina Curtis and her colleagues are working to uncover why recurrence (when breast cancer comes back) and metastasis (when it spreads to other areas of the body beyond the breast and lymph nodes) happens. A BCRF investigator since 2011, Dr. Christina Curtis is an endowed professor of medicine and genetics at Stanford University, where she leads the Cancer ...

The Impact of Chemotherapy on Accelerated Aging in Elderly Patients with Dr. Hyman Muss

July 19, 2022 18:03 - 37 minutes - 12.7 MB

In the latest episode of BCRF’s official podcast, Investigating Breast Cancer, Dr. Hyman Muss explores the need for more research in the geriatric oncology field. Thanks to Dr. Muss and others, much has been learned about breast cancer in elderly people—but there’s still much more to uncover. A BCRF investigator since 2000, Dr. Muss is professor of medicine at the University of North Carolina School of Medicine and director of the Geriatric Oncology Program at the UNC Lineberger Comprehensiv...

Advancing Breast Cancer Immunotherapy and Decoding Treatment Resistance with Dr. Hope Rugo

June 21, 2022 15:01 - 29 minutes - 10.2 MB

What is triple-negative breast cancer and how is it identified? How can triple-negative breast cancers escape the immune system? And how can determining whether circulating tumor DNA in blood samples be used to predict metastatic breast cancer or treatment resistance in patients with aggressive disease? BCRF investigator since 2007, Dr. Hope Rugo answers these questions and many more on the latest episode of Investigating Breast Cancer.

Improving Breast Cancer Care and Narrowing the Health Disparities Gap with Dr. Dawn Hershman

April 19, 2022 13:43 - 21 minutes - 19.3 MB

Many extraordinary new treatments, diagnostic tests, and procedures for breast cancer patients have been introduced in the past decade—and more are needed and sure to come. But researchers are still exploring ways to improve health disparities in cancer care delivery, quality of care, and quality of life for patients and thrivers. In this latest episode, we spoke to BCRF Investigator since 2008, Dr. Dawn Hershman, on ways to shrink these gaps in care.

The Urgent Need for Triple-Negative Breast Cancer Breakthroughs with Dr. Elisa Port

March 01, 2022 16:00 - 31 minutes - 29.2 MB

Triple negative breast cancer (TNBC) makes up about 15 percent of all the breast cancers diagnosed. And, better therapeutic strategies are urgently needed to treat this breast cancer subtype. BCRF Investigator, Dr. Elisa Port is working to combat drug resistance in TNBC by developing a drug for the protein PRKCQ—a promising therapeutic target that may make TNBC more responsive to chemotherapy.

How Diet and Lifestyle Influence Your Breast Cancer Risk with Dr. Graham Colditz

February 02, 2022 18:23 - 34 minutes - 11.7 MB

Can cancers resulting from lifestyle choices be preventable? What foods should you be eating to reduce your risk of breast cancer? And what non-lifestyle decisions should be considered when looking to reduce their risk? Dr. Graham Colditz, a BCRF investigator since 2004, has spent decades diving into these questions and more. Dr. Colditz is an internationally recognized leader in cancer prevention. As an epidemiologist and public health expert, he has a longstanding interest in the preventa...

BCRF’s 2021 Boston Hot Pink Symposium

December 21, 2021 20:19 - 27 minutes - 38.2 MB

BCRF’s annual Boston Hot Pink Luncheon and Symposium convenes the Foundation’s dedicated New England–based supporters to honor the area’s investigators and raise additional funds for lifesaving breast cancer research. This year’s virtual program included an outstanding expert panel of BCRF investigators, moderated by BCRF Scientific Director Dr. Judy Garber. The panelists discussed novel breast cancer therapies and what’s on the horizon in research. The symposium panelists included Dr. Meli...

Artificial Intelligence and the Future of Breast Cancer Research with Dr. Connie Lehman

December 08, 2021 15:57 - 30 minutes - 10.5 MB

Effective medicine has always relied on clear and verifiable diagnoses. Of course, for patients, the wait and uncertainty of diagnostics can be especially trying. BCRF investigator since 2019, Dr. Connie Lehman, is among the scientists and practitioners trying to change that. And she’s doing it in myriad ways to drastically reduce wait times and detect cancers earlier. Dr. Lehman is a professor of radiology at Harvard Medical School, and chief of Breast Imaging and co-director of the Avon C...

Breaking Down Personalized Diagnostics in Breast Cancer with Dr. Joshua LaBaer

November 12, 2021 16:51 - 27 minutes - 37.4 MB

Can breast cancer be found with a blood test? What role do genes and proteins play in developing cancer? What, exactly, are personalized diagnostics? We spoke with BCRF investigator Dr. Joshua LaBaer to answer these questions and more. Dr. LaBaer is one of the country’s foremost investigators in personalized medicine. He serves as executive director of the Biodesign Institute, director of the Biodesign Virginia G. Piper Center for Personalized Diagnostics, and the Dalton Endowed Chair of Ca...

Understanding Global Breast Cancer Disparities with Dr. Temidayo Fadelu

October 14, 2021 18:07 - 36 minutes - 12.6 MB

While academic and medical research has led to incredible breakthroughs in breast cancer care—including new treatments and screening methods—these advances have not reached every patient in every corner of the globe. With breast cancer now the most commonly diagnosed cancer in the world, it’s critical that lifesaving advances are deployed more equitably and universally—especially to women and men in lower-income and -resource countries. Dr. Fadelu discussed his work that lies at the intersec...

Unraveling the Mysteries of Inherited Gene Mutations with Dr. Ephrat Levy-Lahad

September 01, 2021 20:53 - 33 minutes - 46 MB

How can genetic testing data encourage prevention and agency without amplifying personal fear? What can research reveal about genetic markers of risk and predisposition? Or, put differently, how can understanding one’s inherited risk improve approaches to precision prevention? Dr. Ephrat Levy-Lahad is on the forefront of this research, focusing on breast cancer–associated genetic mutations among various populations, including Arab and Ashkenazi Jewish women. She is a professor of internal m...

Perfecting and Personalizing Risk Assessment with Dr. Katherine Nathanson

July 30, 2021 17:25 - 21 minutes - 29.8 MB

While breast cancer is not typically caused by inherited factors, as many as 10-15 percent of people diagnosed with breast cancer carry a known genetic mutation. The most well-known mutations are in the BRCA1 and BRCA2 genes. But these only account for 5-10 percent of inherited breast cancers, so what about the many other gene mutations that increase a person’s risk of breast cancer? Also, what does this mean not only for genetic testing—but also how we should consider results? More signific...

New Approaches to Reducing Repeat Breast Cancer Surgeries with Dr. Mehra Golshan

June 10, 2021 18:53 - 33 minutes - 45.7 MB

There are many challenges in managing breast cancer. Top among them is the fact that initial breast conserving surgeries often miss vestiges of a patient’s tumor. In fact, up to 40 percent of women require another procedure following lumpectomy. Not only can additional surgery, of course, increase a patient’s anxiety and be physically taxing, but it can cause delays in critical subsequent treatments like chemotherapy and radiation. So, why is that rate so high? Why is properly identifying t...

Improving the Quality of Life for Breast Cancer Patients and Survivors with Professor Dame Lesley Fallowfield

May 13, 2021 17:29 - 33 minutes - 11.7 MB

How do you measure quality of life? As researchers across fields discover new drug therapies or disease prevention—in breast cancer as well as other fields—science finds innumerable ways to measure physical results. But what about the social, behavioral, and psychological aspects of cancer care? And how should medical providers discuss such realties with patients? This is just one area of extraordinary impact that Professor Dame Lesley Fallowfield has made in medicine. Dame Lesley is profes...

Understanding Radiation Resistance and Barriers to Quality Care with Dr. Lori Pierce

February 25, 2021 15:06 - 33 minutes - 11.6 MB

For so many breast cancer patients, radiation therapy can bring extraordinary benefits—top among them improved survival rates and reduced recurrence. But there are also challenges and questions: Why do some people experience a recurrence after treatment? How can we reduce side effects? How can we ensure the right patients receive radiation therapy—and that the treatment works as well as possible? These are among the many medical mysteries to which Dr. Lori Pierce, BCRF investigator since 20...

Connecting the Dots Between Breast Cancer Risk and Obesity, with Dr. Vared Sterns

January 27, 2021 17:57 - 32 minutes - 44.3 MB

Women with breast cancer who are overweight or obese experience inferior outcomes compared to those with normal weight despite receiving optimal therapies. Dr. Vered Stearns discusses researching ways to reduce breast cancer recurrence through effective weight-loss interventions and why we need to bring more discoveries from the lab to the clinic. Dr. Stearns is a member of the BCRF Scientific Advisory Board and has been a BCRF Investigator since 2003.

BCRF Symposium and Awards Luncheon 2020

December 10, 2020 16:27 - 46 minutes - 16.1 MB

Each October, BCRF-funded investigators are honored at the Foundation’s Symposium & Awards Luncheon in New York City. This year, the program was held virtually, without the lunch—but with all of the important conversations and ideas. The annual event announces the Foundation’s grant investment for the coming year and recognizes BCRF investigators for their trailblazing scientific inquiry. This year’s program included an extraordinary symposium, moderated by BCRF Scientific Director Dr. Judy...

Improving National and Global Racial Disparities in Breast Cancer Care with Dr. Funmi Olopade

November 25, 2020 15:17 - 53 minutes - 18.2 MB

Women of African descent are more likely to be diagnosed with aggressive breast cancers than white women and are more likely to die from their disease regardless of its type or stage. For those living in remote or low-resource areas, limited access to screening and genetic testing make improving outcomes even more challenging. In this episode of our podcast, Dr. Funmi Olopade, talks about her work in Africa and Chicago, the critical importance of precision medicine, and why she’s “impatient...

A Closer Look at the Evolution of Breast Cancer Cells with Dr. Kornelia Polyak

October 28, 2020 20:05 - 37 minutes - 51.8 MB

The immune system plays a critical role in tumor growth by attacking cancer cells with white blood cells. Cancer cells that survive this immune attack can become invasive and metastatic (a process called immune escape). In this episode of Investigating Breast Cancer, Dr. Kornelia Polyak shares the impact of understanding breast cancer at a molecular level. Dr. Polyak, a BCRF investigator since 2008, is an internationally recognized leader in the breast cancer research field. 

Exploring the Many Intersections of Health Equity in Latin America with Dr. Jeffrey Weitzel

September 28, 2020 17:38 - 39 minutes - 54.6 MB

While genetic testing and counseling for breast cancer has been available in the U.S. for many years, accessing these services in Mexico and the rest of Latin America is more challenging due to limited resources. Leading genetics researcher and oncologist, Dr. Jeffrey Weitzel, has devoted his career to decreasing these barriers. Dr. Weitzel, a BCRF investigator since 2013, is director of the Clinical Cancer Genetics Program and professor of oncology and population sciences at the Beckman Res...

Closing the Gap in Breast Cancer Care with Dr. Mariana Chavez MacGregor

August 05, 2020 20:52 - 32 minutes - 11.2 MB

Research shows that when chemotherapy is delayed, a patient’s chance of survival falls significantly. Dr. Mariana Chavez MacGregor, a BCRF investigator since 2018, joined our podcast to talk about her work with underserved and underinsured patients—those who are most likely to experience delays—to develop personalized ways to improve healthcare access and, ultimately, outcomes. Dr. MacGregor is an associate professor at the University of Texas MD Anderson Cancer Center, holding a primary ap...

The Promise and Potential of Breast Cancer Vaccines with Dr. Karen Anderson

June 30, 2020 21:48 - 29 minutes - 10.1 MB

One key goal in developing precision vaccines and immune therapies is to reduce the risk of breast cancer recurrence. Yet currently, there is only one FDA-approved immunotherapy drug for breast cancer, and it benefits just a small subset of women. In this episode of Investigating Breast Cancer, we talk with Dr. Karen Anderson about vaccines, harnessing the power of a person’s immune system, and reducing the risk of breast cancer recurrence. And of course, we’d all like to know: What’s the p...

The Underlying Biology of Drug Resistance with Dr. Sarat Chandarlapaty

May 28, 2020 19:27 - 34 minutes - 11.8 MB

Advances in cancer therapy have dramatically contributed to the decline in breast cancer deaths over the last three decades. But even with these advances, drug resistance—when tumors stop responding to anti-cancer drugs—remains a serious clinical challenge. Dr. Sarat Chandarlapaty talks about the strategies to prevent cancer cells from evading the drugs designed to kill them.  Dr. Chandarlapaty is a laboratory head at the Human Oncology and Pathogenesis Program at the Memorial Sloan Ketteri...

A Cross-disciplinary Approach to Breast Cancer Research with Dr. Antonio Wolff

April 28, 2020 19:13 - 41 minutes - 57.1 MB

 In the fight to understand and solve breast cancer, “it takes a village.” In this case, the village is more like a globally connected series of research labs, scientists, patients, funders and more. In other words, something that looks a lot like the Translational Breast Cancer Research Consortium (TBCRC). The TBCRC is a collaborative group founded in 2005 to conduct innovative and high-impact clinical trials for breast cancer led by Dr. Antonio Wolff. Dr. Wolff, a BCRF investigator since 2...

Breast Cancer Care and COVID-19: From the Frontlines with Dr. Judy Garber

March 24, 2020 15:36 - 22 minutes - 7.58 MB

Breast cancer—and any cancer—can be incredibly stressful under the best of circumstances for patients, survivors, and their families. In this time of the novel coronavirus (COVID-19), concerns can feel like they’re rising exponentially. So, what do we all need to know? With tons of new information bombarding us at once, what should cancer patients and families consider? Are there practical tactics or is there tangible guidance to stay safe?  In this special episode of Investigating Breast C...

Developing Personalized Risk Prediction with Dr. Mark Robson

February 28, 2020 19:39 - 29 minutes - 10 MB

Dr. Mark Robson talks about how he’s working to help identify the right tests for the right person at the right age How can researchers provide more precise risk estimates so that individuals with inherited risks can make informed decisions about their health, so that the right women are getting the right tests at the right age? Dr. Robson is conducting studies that employ advanced technologies that incorporate information from genetic tests to enhance the precision of genetic risk assessme...

Unraveling Metastatic Breast Cancer, with Dr. Martine Piccart

January 17, 2020 14:41 - 30 minutes - 41.6 MB

Dr. Martine Piccart talks to us about the power of collaboration in metastatic breast cancer research Metastasis, the spread of cancer cells from the breast to other sites in the body, is responsible for nearly all breast cancer deaths. Approximately 150,000 men and women are diagnosed with metastatic breast cancer each year. Today, BCRF is the largest private funder of this critical area of research. Dr. Martine Piccart is passionate about metastasis research and the vital role that inter...

Young women and breast cancer, with Dr. Ann Partridge

December 20, 2019 20:46 - 41 minutes - 76.7 MB

For young women, a breast cancer diagnosis presents a unique set of challenges not only due to age, but the biology of the disease as well. While a diagnosis under the age of 40 is rare, the disease tends to behave more aggressively. Compared to older breast cancer patients, young women treated for the disease tend to have an increased risk of experiencing emotional distress, treatment-induced sexual dysfunction, and concerns about future pregnancies.   This is where Dr. Ann Partridge steps i...

BCRF Symposium & Awards Luncheon: Live from New York City

December 02, 2019 19:00 - 1 hour - 24.7 MB

Every October, BCRF-funded researchers are honored at the annual Symposium & Awards Luncheon in New York City. This is when BCRF makes its formal announcement of research grants for the upcoming year and recognizes its investigators for their devotion to ending breast cancer with their trailblazing scientific inquiry. The event provides a unique opportunity for BCRF researchers to convene, share ideas and collaborate with fellow colleagues from around the world. This year’s program began wit...

Mapping and understanding brain metastasis in breast cancer, with Dr. Priscilla Brastianos

October 11, 2019 13:34 - 29 minutes - 10.1 MB

Metastasis, when cancer cells leave the breast and spread to other sites in the body, is the major cause of mortality from breast cancer. The brain is one of the most common organs breast cancer invades, occurring in more than one third of patients with advanced breast cancer, up to 300,000 patients a year. The prognosis of cancer patients who develop brain metastasis is poor, with only 20 percent of patients surviving at one year. For Dr. Priscilla Brastianos, a BCRF investigator since 201...

The De-Escalation of Therapy, with Dr. Eric Winer

September 25, 2019 21:28 - 32 minutes - 59.3 MB

How should we – patients, family, doctors – consider the careful balance in identifying patients who might benefit from less rigorous course of treatment?  Dr. Eric Winer, a BCRF investigator since 2003, studies this concept. Known as “de-escalation of therapy,” this form of personalized medicine challenges the “one-size-fits-all” approach to breast cancer treatment. His current BCRF-supported study aims to improve quality of life by reducing post-surgery chemotherapy in carefully selected ...

What Should I Eat? We asked Dr. Walter Willett

August 16, 2019 12:48 - 35 minutes - 12.1 MB

“What should I eat?” It’s a question that Dr. Walter Willett thinks about every day as a researcher focused on the intersection of diet, lifestyle and health.   Dr. Willett, a BCRF investigator since 2001, is widely considered a global leader on nutrition research. His research aims to characterize the impact of diet and lifestyle on health outcomes, especially in relation to breast cancer risk. As the most cited nutritionist worldwide, his work has influenced numerous health recommendations ...

Improving breast cancer diagnosis and care in remote and low resource communities, with Dr. Lawrence Shulman

July 12, 2019 12:12 - 29 minutes - 10 MB

Did you ever think you’d end up working in Africa?Neither did Dr. Lawrence Shulman. But then we never had Paul Farmer as our intern. Dr. Shulman – an oncologist who specializes in breast cancer – did.Farmer, if you don’t know, is the American anthropologist and doctor who in 1987 co-founded Partners in Health, an international non-profit that, in its own words, brings “health care to the world’s poorest families.” That means in places like Haiti and Rwanda.Which is why some eight years ago, ...

Focusing on early treatment, with Dr. Luca Gianni

June 14, 2019 20:10 - 31 minutes - 10.7 MB

You likely know the expression, Pay It Forward. It’s an important concept for any kind of social awareness, but it can carry special meaning as well in the breast cancer world, particularly in research.That’s because so much of today’s important breakthroughs are built not only on yesterday’s participation of other patients, but, of course, the work of other researchers. It’s a sentiment Dr. Luca Gianni not only knows well, but also puts into practice every day.As you’ll hear, in this import...

Evaluating natural cancer treatments with Dr. Susan Horwitz

May 09, 2019 20:40 - 31 minutes - 10.7 MB

Can life change with a single letter in the mail? For my guest today, it did, and subsequently, so did the lives of millions of people with various forms of cancer, including breast cancer. The letter in question came from the National Cancer Institute in 1977. The recipient was Dr. Susan Horwitz. The result: The creation of one of the most important cancer drugs that come from a natural product: Taxol, which is isolated from the yew plant. Today it is given to over a million patients. As y...